386 252

Cited 7 times in

Development of a transgenic mouse model of hepatocellular carcinoma with a liver fibrosis background

Authors
 Sook In Chung  ;  Hyuk Moon  ;  Dae Yeong Kim  ;  Kyung Joo Cho  ;  Hye-Lim Ju  ;  Do Young Kim  ;  Sang Hoon Ahn  ;  Kwang-Hyub Han  ;  Simon Weonsang Ro 
Citation
 BMC Gastroenterology, Vol.16(13) : 1-9, 2016 
Journal Title
 BMC Gastroenterology 
Issue Date
2016
MeSH
Animals ; Carbon Tetrachloride ; Carcinogenesis/metabolism ; Carcinoma, Hepatocellular/etiology* ; Carcinoma, Hepatocellular/metabolism ; Disease Models, Animal ; Genes, myc/genetics ; Genes, p53 ; Hepatic Stellate Cells/metabolism ; Liver/metabolism ; Liver/pathology ; Liver Cirrhosis, Experimental/chemically induced ; Liver Cirrhosis, Experimental/complications* ; Liver Neoplasms/etiology* ; Liver Neoplasms/metabolism ; Liver Neoplasms, Experimental/etiology* ; Liver Neoplasms, Experimental/metabolism ; Mice ; Mice, Transgenic ; RNA, Small Interfering ; Transposases/metabolism
Keywords
Transgenic mouse ; Hepatocellular carcinoma ; Fibrosis ; Hydrodynamic transfection ; Liver injury
Abstract
BACKGROUND: Liver fibrosis and its end-stage disease, cirrhosis, are major risk factors for hepatocellular carcinoma (HCC) and present in 80 to 90 % of patients with HCC. Current genetically engineered mouse models for HCC, however, generally do not feature liver fibrosis, which is a critical discrepancy between human HCC and murine models thereof. In this study, we developed a simple transgenic mouse model of HCC within the context of a fibrotic liver. METHODS: Employing hydrodynamic transfection (HT), coupled with the Sleeping Beauty (SB) transposon system, liver was stably transfected with transposons expressing cMyc and a short hairpin RNA down-regulating p53 (shp53). A chronic liver injury model, induced by hepatotoxic carbon tetrachloride (CCl4), was applied to the transgenic mice, allowing cells expressing cMyc plus shp53 to become malignant in the background of liver fibrosis. RESULTS: Livers harvested about 3 months after HT had excessive collagen deposition and activated hepatic stellate cells surrounding the tumors. Hepatocarcinogenesis was significantly accelerated in the fibrotic livers compared to those of the control, significantly decreasing the life span of the mice. The tumor incidence and average number of tumors per mouse were significantly higher in the group treated with CCl4 compared to the vehicle-treated control mice, following HT (p < 0.01). CONCLUSIONS: Considering the simplicity and efficiency in generating HCC for fibrotic livers, the transgenic HCC model has the potential to be effectively used in preclinical testing of HCC anticancer therapy and in studies of hepatocarcinogenesis in fibrotic livers.
Files in This Item:
T201600301.pdf Download
DOI
10.1186/s12876-016-0423-6
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers
5. Research Institutes (연구소) > Liver Cirrhosis Clinical Research Center (간경변증임상연구센터) > 1. Journal Papers
1. College of Medicine (의과대학) > Yonsei Biomedical Research Center (연세의생명연구원) > 1. Journal Papers
Yonsei Authors
김도영(Kim, Do Young)
노원상(Ro, Simon Weonsang) ORCID logo https://orcid.org/0000-0003-2187-3698
안상훈(Ahn, Sang Hoon) ORCID logo https://orcid.org/0000-0002-3629-4624
정숙인(Chung, Sook In) ORCID logo https://orcid.org/0000-0002-7915-9203
한광협(Han, Kwang-Hyub) ORCID logo https://orcid.org/0000-0003-3960-6539
Export
RIS (EndNote)
XLS (Excel)
XML
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/146363
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse